International Clinical Trial: Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455903) titled 'Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Baptist Health South Florida

Condition: Prostate Cancer Localized Prostate Carcinoma

Intervention: Drug: Leuprolide Drug: Degarelix Drug: Relugolix Drug: Triptorelin Drug: Bicalutamide Diagnostic Test: 18-F Flotufolastat PSMA PET

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enr...